Fisetin: The Senolytic Flavonoid That Clears Zombie Cells

The Flavonoid That Kills Zombie Cells

Your body accumulates "zombie cells" as you age. These are senescent cells — cells that have stopped dividing but refuse to die. Instead, they linger in your tissues, secreting a toxic cocktail of inflammatory molecules called the SASP (senescence-associated secretory phenotype). This damages neighbouring healthy cells, drives chronic inflammation, and accelerates aging.

In 2018, researchers at the Mayo Clinic screened 10 flavonoids for their ability to selectively kill these zombie cells. One compound stood out above all others: fisetin. It was the most potent natural senolytic they tested — more effective than quercetin, luteolin, or curcumin at clearing senescent cells in human tissue.

Since then, fisetin has gone from relative obscurity to one of the most exciting compounds in longevity research. Multiple clinical trials are underway. The longevity community has taken notice. And the science is genuinely compelling.

Related reading: The 12 Hallmarks of Aging · What Is Autophagy? · Resveratrol Benefits

---

What Is Fisetin?

Fisetin (3,3',4',7-tetrahydroxyflavone) is a flavonoid polyphenol found in small quantities in several fruits and vegetables:

Even from the richest source (strawberries), you'd need to eat approximately 37 cups of strawberries to reach a single 500mg research dose. Supplementation is the only practical way to achieve therapeutic levels.

---

How Fisetin Works as a Senolytic

Understanding Cellular Senescence

When cells are damaged beyond repair — by UV radiation, oxidative stress, telomere shortening, or oncogene activation — they have two options:

1. Apoptosis (programmed cell death) — the clean option. The cell dies, is cleared by immune cells, and is replaced
2. Senescence — the problematic option. The cell survives but stops dividing, entering a permanent growth arrest

Senescent cells serve a purpose in youth: they prevent damaged cells from becoming cancerous and help with wound healing. But with age, the immune system becomes less efficient at clearing them, and they accumulate. A 60-year-old has roughly 100× more senescent cells than a 20-year-old.

The SASP Problem

Senescent cells wouldn't be so harmful if they sat quietly. Instead, they actively damage their environment through the SASP — a cocktail of:

• Pro-inflammatory cytokines (IL-6, IL-8, TNF-α)
• Matrix metalloproteinases (MMPs) that degrade tissue structure
• Growth factors that can promote cancer
• Chemokines that recruit immune cells and perpetuate inflammation

The SASP creates a toxic microenvironment that:

• Converts neighbouring cells to senescence (spreading the problem)
• Drives chronic low-grade inflammation (Hallmark #11)
• Disrupts tissue function
• Promotes age-related diseases (atherosclerosis, osteoarthritis, fibrosis, neurodegeneration)

Fisetin's Senolytic Mechanism

Fisetin selectively kills senescent cells through several pathways:

1. Inhibits PI3K/Akt survival pathway — senescent cells rely on this pro-survival signalling to avoid apoptosis. Fisetin blocks it
2. Downregulates BCL-2 family — anti-apoptotic proteins that keep senescent cells alive. Fisetin reduces their expression
3. Activates caspase-3 — the "executioner" enzyme of apoptosis, specifically in senescent cells
4. Reduces SASP production — even in senescent cells that aren't killed, fisetin suppresses their inflammatory output

The key word is selective. Fisetin preferentially targets senescent cells while sparing healthy, normally dividing cells. This selectivity is what makes it a true senolytic rather than a general cytotoxic agent.

---

The Evidence: Key Research

The Mayo Clinic Study (2018)

The landmark study that put fisetin on the map. Published in EBioMedicine by Yousefzadeh et al.:

• Screened 10 flavonoids for senolytic activity
• Fisetin was the most potent — reduced senescent cell markers more effectively than any other compound tested
• In aged mice, fisetin treatment extended median lifespan by approximately 10% and reduced age-related pathology
• Reduced senescent cells in multiple tissues simultaneously (fat, liver, kidney)

AFFIRM Trial (Ongoing)

The largest clinical trial of fisetin to date:

• Full name: Alleviation of Frailty, Inflammation, and Related Measures in Older Adults
• Design: Randomised, double-blind, placebo-controlled
• Dose: 20mg/kg body weight for 2 consecutive days (approximately 1,400mg/day for a 70kg adult)
• Protocol: Repeated monthly
• Endpoints: Frailty, inflammatory markers, senescent cell burden, physical function
• Status: Recruiting/ongoing at Mayo Clinic

Additional Research

• Neuroprotection: Multiple animal studies show fisetin protects against neurodegeneration, improves memory, and reduces neuroinflammation. A 2014 study in Aging Cell showed fisetin prevented age-related cognitive decline in mice
• Anti-inflammatory: Fisetin inhibits NF-κB, COX-2, and multiple inflammatory pathways independently of its senolytic effects
• Anti-cancer: Preclinical studies show anti-proliferative effects across multiple cancer types (the senolytic effect may contribute to cancer prevention by removing precancerous senescent cells)
• Diabetic complications: Fisetin reduced kidney damage and improved metabolic markers in diabetic animal models

---

Fisetin vs Quercetin: The Senolytic Showdown

Both are flavonoids with senolytic properties, but they differ significantly:

Can You Stack Them?

Yes — and there's rationale for doing so. Fisetin and quercetin target different aspects of senescent cell biology:

• Fisetin primarily disrupts PI3K/Akt survival signalling
• Quercetin primarily inhibits BCL-2/BCL-xL anti-apoptotic proteins

Together, they attack senescent cell survival from multiple angles. Some longevity practitioners use both in their periodic senolytic protocols.

---

Dosing Protocols

The Senolytic Pulse Protocol

Unlike daily supplements, senolytics may work best when taken in periodic high-dose "pulses" — killing a batch of senescent cells, then allowing the body to clear the debris and recover.

Research-based protocol (from AFFIRM trial):

• Dose: 20mg/kg body weight (approximately 1,400mg for a 70kg person)
• Duration: 2 consecutive days
• Frequency: Once per month
• Timing: With a fat-containing meal for absorption

Conservative protocol (commonly used in longevity community):

• Dose: 500–1,000mg
• Duration: 2–3 consecutive days
• Frequency: Once per month or every 6–8 weeks
• Timing: Morning with fat-containing breakfast

The Daily Low-Dose Protocol

Some people take fisetin daily at lower doses for its anti-inflammatory and neuroprotective benefits (distinct from its senolytic effects):

• Dose: 100–200mg daily
• Purpose: Anti-inflammatory, cognitive support, antioxidant
• Note: This dose is likely insufficient for meaningful senolytic clearance — it targets fisetin's other mechanisms

Important Considerations

• Pulse vs daily: The senolytic field is still debating optimal protocols. The pulse approach has stronger theoretical support (you want acute, high-dose exposure to overwhelm senescent cell defences)
• Cycling: Allow 4–8 weeks between senolytic pulses for tissue remodelling and immune clearance of dead cells
• First-time users: Start with a single day at 500mg to assess tolerance before attempting full pulse protocol

---

Fisetin in Longevity Stacks

The Senolytic Stack

• Fisetin (1,000mg, 2 days/month) — primary senolytic
• Quercetin (500mg, same 2 days) — complementary senolytic
• Omega-3 (2g daily) — supports resolution of inflammation after senescent cell clearance

The Comprehensive Longevity Stack

• Daily: NMN (250mg) + Resveratrol (250mg) + Spermidine (5mg) + CoQ10 (200mg)
• Monthly pulse (2 days): Fisetin (1,000mg) + Quercetin (500mg)
• Always: Omega-3 (2g daily), Vitamin D (2,000 IU daily)

This stack targets the most actionable hallmarks of aging: NAD+ decline (NMN), sirtuin activation (resveratrol), autophagy (spermidine), mitochondrial function (CoQ10), and cellular senescence (fisetin/quercetin).

---

Safety and Side Effects

Fisetin's safety profile is good, though less extensively studied than older supplements:

What We Know

• Preclinical toxicity studies show no significant adverse effects
• The AFFIRM trial uses high doses (20mg/kg) with an acceptable safety profile reported so far
• Most common reported effects: Mild GI discomfort during high-dose pulses (transient)
• No serious adverse events reported in published research at standard doses

Cautions

What We Don't Yet Know

• Long-term effects of repeated senolytic pulses in humans
• Optimal pulse frequency and duration
• Whether daily low-dose fisetin accumulates differently than periodic high-dose
• Interactions with specific medications beyond anticoagulants

This honest uncertainty is important. Fisetin is one of the most promising longevity compounds, but the human clinical data is still emerging. The AFFIRM trial results will be landmark when published.

---

The Bioavailability Challenge

Like most polyphenols, fisetin has limited bioavailability:

• Low aqueous solubility restricts absorption from the gut
• Extensive first-pass metabolism reduces the amount reaching systemic circulation
• Short half-life means peak blood levels are transient

Improving Fisetin Absorption

---

Frequently Asked Questions

Can I get enough fisetin from strawberries?

You'd need approximately 37 cups of strawberries to reach a single 500mg dose. Eating strawberries is healthy for many reasons, but it's not a viable fisetin supplementation strategy. Supplements are necessary for therapeutic doses.

How often should I do a fisetin pulse?

The AFFIRM trial uses monthly pulses. Many longevity practitioners use monthly or every-6-week protocols. There's no definitive answer yet — the field is still optimising frequency. Monthly is reasonable based on current understanding.

Is fisetin safe to take every day?

At low doses (100–200mg), daily fisetin appears safe based on available data. However, daily use targets its anti-inflammatory and antioxidant properties — not its senolytic effects. For senolytic clearance, periodic high-dose pulses are recommended.

Does fisetin work without quercetin?

Yes — fisetin is a standalone senolytic. The Mayo Clinic study showing it as the most potent natural senolytic used fisetin alone. Quercetin is complementary but not required.

How will I know if fisetin is working?

You likely won't feel dramatic effects immediately. Senescent cell clearance is a background process. Over months, some people report improved energy, reduced joint stiffness, better skin quality, and reduced inflammation markers (measurable via blood tests). The benefits are cumulative and gradual.